As glioblastoma has a sub-population of stem cells capable of self-renewal and radiotherapy resistance, the response of prominin-1/CD133 to ATRA in U87MG may potentially serve as a GBM cell line model for targeted differentiation strategies. Here, PROM1 is linked to glioblastoma.